BEMPEDOIC ACID 180 MG + EZETIMIBE 10 MG FIXED-DOSE COMBINATION VS EZETIMIBE ALONE OR PLACEBO IN PATIENTS WITH TYPE 2 DIABETES AND HYPERCHOLESTEROLEMIA

Autor:	Christie M. Ballantyne, Harold Bays, Eliot Brinton, Seth J. Baum, JoAnn Flaim, Jorge Plutzky, Zhan Ye
Rok vydání:	2020
Předmět:	medicine.medical_specialty Ezetimibe 10 MG endocrine system diseases business.industry Fixed-dose combination nutritional and metabolic diseases Type 2 Diabetes Mellitus Phases of clinical research Type 2 diabetes 030204 cardiovascular system & hematology Placebo medicine.disease Gastroenterology 03 medical and health sciences 0302 clinical medicine Ezetimibe Internal medicine medicine lipids (amino acids peptides and proteins) 030212 general & internal medicine Cardiology and Cardiovascular Medicine business Bempedoic acid medicine.drug
Zdroj:	Journal of the American College of Cardiology. 75:1983
ISSN:	0735-1097
DOI:	10.1016/s0735-1097(20)32610-3
Popis:	Patients with type 2 diabetes mellitus (T2DM) are at high cardiovascular risk. National and international guidelines recommend aggressive low-density lipoprotein cholesterol (LDL-C) lowering with statin therapy; however, statins may increase glucose levels. This phase 2 study was the first to
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::15377c870d03fed13ee9eb382929cd00 https://doi.org/10.1016/s0735-1097(20)32610-3 Zobrazit plný text záznamu